For almost three years, scientists have raced to understand the immune responses in patients who develop severe COVID-19, with an enormous effort aimed at defining where healthy immunity ends and destructive immunity begins.
In the early days of the COVID-19 pandemic, much attention focused on reports of harmful inflammation and so-called cytokine storms dangerous immune overreactions that can lead to tissue damage and death in patients with severe COVID-19. It wasnt long before researchers began to identify antibodies that target the patients own body rather than attacking SARS-CoV-2, the virus the causes COVID-19.
Those studies revealed that patients with severe COVID-19 share some of the key traits of chronic autoimmune diseases diseases in which the patients immune systems chronically attack their own tissues. Scientists have long suspected and sometimes even documented links between viral infection and chronic autoimmune diseases, but the research remains murky. However, the COVID-19 pandemic has offered an opportunity to better understand potential connections between these conditions.
As an immunologist and member of an interdisciplinary team of physicians and scientists investigating the intersection between COVID-19 and autoimmunity, I have been working to understand the origins of these untamed antibody responses and their long-term effects. Led by Ignacio Sanz, a specialist in investigating the immune dysfunctions that underlie autoimmune diseases like lupus, our group has long suspected that these misdirected immune responses may follow patients well after recovery and could even contribute to the debilitating set of symptoms commonly referred to as long COVID-19.
Our new study, published in the journal Nature, helps shed light on these questions. We now know that in patients with severe COVID-19, many of the developing antibodies responsible for neutralizing the viral threat are simultaneously targeting their own organs and tissues. We also show that self-directed antibodies can persist for months or even years in those suffering from long COVID-19.
As researchers like us continue to study COVID-19, our understanding of the link between antiviral immunity and chronic autoimmune disease is rapidly evolving.
Its easy to assume that your immune system is laser-focused on identifying and destroying foreign invaders, but that isnt the case at least under some circumstances. Your immune system, even in its healthy state, contains a contingent of cells that are fully capable of targeting and destroying your own cells and tissues.
To prevent self-destruction, the immune system relies on an intricate series of fail-safes that are collectively termed self-tolerance to identify and eliminate potentially traitorous immune cells. One of the most important steps in this process occurs as the immune system builds up its arsenal against a potential threat.
When your immune system first encounters a pathogen or even a perceived threat such as a vaccine that resembles a virus it rapidly recruits B cells that have the potential to become antibody-producers. Then, any of these naive B cell recruits naive being a technical term used in immunology that demonstrate an ability to competently attack the invader are put into a boot camp of sorts.
Here, the cells are trained to better recognize and combat the threat. The training period is intense and mistakes are not tolerated; B cells with any discernible potential for misdirected attacks against their host are killed. However, like any training process, this buildup and mobilization takes time typically a week or two.
So, what happens when the threat is more immediate when someone is quite literally fighting for their life in an intensive care unit?
Researchers now know that under the stress of severe viral infection with SARS-CoV-2, that training process collapses. Instead, it is replaced by an emergency response in which new recruits with little training are rushed into battle.
Friendly fire is the unfortunate result.
Our teams new work reveals that in the heat of battle with severe COVID-19, the same antibodies responsible for fighting the virus are uncomfortably prone to targeting a patients own tissue. Importantly, this effect seems mostly restricted to severe disease. We identified the cells that produce these rogue antibodies much less frequently in patients with mild forms of the illness whose immune responses were more measured.
So, does that mean that everyone who gets severe COVID-19 develops an autoimmune disorder?
Fortunately, no. By following patients after their infection has resolved, we have found that months later, most of the concerning indications of autoimmunity have subsided. And this makes sense. Though we are identifying this phenomenon in human COVID-19, researchers studying these emergency immune responses for more than a decade in mice have determined that they are mostly short-lived.
Mostly being the operative word.
Although most people fully recover from their run-in with the virus, up to 30% have not returned to normal even three months after recovery. This has created a group of patients who are experiencing what is known as post-acute sequelae of COVID-19, or PASC the technical terminology for long COVID-19.
With debilitating symptoms that can include the long-term loss of taste, smell or both, general fatigue, brain fog and a variety of other conditions, these patients have continued to suffer and are rightfully looking for answers.
An obvious question for researchers who are studying these patients is whether the same self-targeted antibodies that are emerging in severe COVID-19 are lingering in those who suffer from long COVID-19. They are. Our new study makes clear that newly developed self-antibodies can persist for months. Whats more, in work currently under development and not yet peer-reviewed, we find that these responses are not restricted to those recovering from severe illness, and are readily identifiable in a large subset of long COVID-19 patients who had recovered from more mild illness as well.
Just as it was in the race to better understand the causes of acute disease earlier in the pandemic, we researchers are now working to get a more complete understanding of the cells and antibodies directing this self-attack for months and years following the resolution of infection.
Are they directly contributing to the symptoms long COVID-19 sufferers are experiencing? If so, are there therapeutic interventions that could blunt or eliminate the threats they pose? Are long COVID-19 patients at increased risk for the development of true, chronic autoimmune diseases in the future? Or, is all of this just a red herring a temporary quirk of the immune system that will resolve on its own?
Only time and continued work in this critical area will tell.
Go here to read the rest:
Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk behind it - The Conversation Indonesia
- Overview of the Immune System - The Merck Manuals - March 18th, 2024
- What are the organs of the immune system? - InformedHealth.org - NCBI ... - January 17th, 2024
- Mom who homeschools her children reveals she lets her one-year-old play in and EAT mud - but insists it is goo - Daily Mail - November 26th, 2023
- The limits of nutritional supplements: they dont cure or prevent ailments, nor are they harmless - EL PAS USA - November 26th, 2023
- Here's how your gut affects your mental health, immune function and even cardiovascular health - indulgexpress - November 18th, 2023
- From fear to freedom: Anchor Paul LaGrone shares his story of sudden hair loss & the disease that caused it - ABC Action News Tampa Bay - May 9th, 2023
- Strengthen Your Immune System With 4 Simple Strategies - May 1st, 2023
- Immunodeficiency Awareness Month: What Is The Science Behind These Diseases? Know Warning Signs - ABP Live - May 1st, 2023
- Nearly 90% of patients with rare skin cancer respond to therapy that prevents tumors from evading the immune - cleveland.com - April 23rd, 2023
- University of Cincinnati researchers helping develop 'vaccine' to fight aggressive cancer - WKRC TV Cincinnati - April 23rd, 2023
- Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with... - April 23rd, 2023
- Immune System: Parts & Common Problems - Cleveland Clinic - March 21st, 2023
- Disorders of the Immune System | Johns Hopkins Medicine - March 21st, 2023
- Sometimes 15 Minutes Are More Than Enough To Improve Immune System, Sleep Quality And Depression - Revyuh - March 13th, 2023
- People produce endocannabinoids similar to compounds found in marijuana that are critical to many bodily functions - The Conversation Indonesia - February 24th, 2023
- Spending more time with your kids, grandkidsand their germsmay lower risk of a severe outcome from Covid-19, recent studies show - CNBC - December 20th, 2022
- Published in Journal for Immunotherapy of Cancer: Using Single-Cell Analysis to Assess the Effects of an Anti-OX40 Monoclonal Antibody in Its... - November 17th, 2022
- Man who had COVID-19 for 400 days finally cured after getting treated with antibodies, study says - msnNOW - November 17th, 2022
- Social Distancing: The Impact on Your Health and Immune System - Healthline - October 7th, 2022
- Unraveling the Mysteries of the Immune System - Duke University School of Medicine - October 7th, 2022
- When Will ISR Immune System Regulation Holding AB (publ) (STO:ISR) Become Profitable? - Simply Wall St - October 7th, 2022
- VitaGaming Introduces Immune Support and Collagen to help Gamers boost immunity and fight stress - PR Web - October 7th, 2022
- Ohio reports third U.S. death of person with monkeypox who had underlying health conditions - CNBC - October 7th, 2022
- How a select few people have been cured of HIV - PBS - October 7th, 2022
- BeniCaros Wins Nutrition Industry Executive 2022 Immune Health Award - GlobeNewswire - October 7th, 2022
- Seasonal superfoods to give your immune system a boost this autumn - Yahoo Entertainment - October 7th, 2022
- Whats Going Around: Flu cases confirmed locally - ABC27 - October 7th, 2022
- Contributor: How to Fight the Cold and the Flu This Season - AJMC.com Managed Markets Network - October 7th, 2022
- Updated COVID-19 Bivalent Booster Released in Time for Fall and Winter Omicron Wave - Cornell University The Cornell Daily Sun - October 7th, 2022
- Oralair pill that retrains the immune system to reduce risk of thunderstorm asthma - 7NEWS - October 7th, 2022
- COVID immune reaction could affect brain mechanisms and induce neurological symptoms - Sky News - October 7th, 2022
- 7 Surprising Health Benefits of Pumpkins - AARP - October 7th, 2022
- Why Do Some Allergies Go Away While Others Dont? - The Atlantic - October 7th, 2022
- 15 foods to boost the immune system - Medical News Today - September 4th, 2022
- The powerful supplement that could enhance your immune response to bacteria and viruses - Express - September 4th, 2022
- New research: Cancer-fighting viruses can boost body's immune response - The Indian Express - September 4th, 2022
- Study raises concerns about the effectiveness of the monkeypox vaccine - STAT - September 4th, 2022
- Five Natural Immune-Boosting Treatments to Try This Flu Season - Boston magazine - September 4th, 2022
- Returning to Football After COVID-19 Infection - Louisiana State University - September 4th, 2022
- #1 Best Way to Boost Your Immunity Against BA.5 Eat This Not That - Eat This, Not That - September 4th, 2022
- Whatever happened to the Botswana scientist who identified omicron then caught it? - NPR - September 4th, 2022
- Non-Hodgkin's lymphoma: What is the cancer that Jane Fonda announced she has? - FOX 29 Philadelphia - September 4th, 2022
- 8 Health Benefits of Cabbage - Health Essentials - September 4th, 2022
- Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features - BMC Women's... - September 4th, 2022
- VICTOR DAVIS HANSON: The mysteries of Long COVID - Las Vegas Review-Journal - September 4th, 2022
- Is This Popular Montana City The Most Depressed In The Nation? - XL Country - September 4th, 2022
- First adapted COVID-19 booster vaccines recommended for approval in the EU | European Medicines Agency - European Medicines Agency | - September 4th, 2022
- Potential of Vaccines in Treating Parkinson's, Alzheimer's Detailed | AC Immune to Launch Trial of Vaccine in Early-stage Parkinson's - Parkinson's... - September 4th, 2022
- What Are Zombie Cells? Here's How They Impact Aging - Prevention Magazine - September 4th, 2022
- What To Know About Hand, Foot and Mouth Disease - Health Essentials - September 4th, 2022
- On maternity and the stronger immune response in women - Nature.com - August 19th, 2022
- New study could change what we eat to supercharge immune system and fight disease - WOODTV.com - August 19th, 2022
- Extending dogs' lives, and sex and the immune system - MIT Technology Review - August 19th, 2022
- Your Immune System Will Thrive With This Elderberry Hill Liquid Morning Multivitamin - Men's Journal - August 19th, 2022
- Sure Signs Your Immune System Isn't as Strong as it Should Be Eat This Not That - Eat This, Not That - August 19th, 2022
- Can the monkeypox vaccine stop the current outbreak? : Goats and Soda - NPR - August 19th, 2022
- Getting A Grip On Influenza: The Pursuit Of A Universal Vaccine (Part 2) - Forbes - August 19th, 2022
- Bells Are Ringing! How Immunotherapy is Unlocking Doors to a Cancer Cure - Georgetowner - August 19th, 2022
- Have The Immune System Booster Through the Dietary Supplements Only from Berkeley Immune Support Formula - Digital Journal - August 19th, 2022
- COVID-19 and Flu Viruses Often Have a Deadly Accomplice: Bacterial Infections - Tufts Now - August 19th, 2022
- Eat This Fruit Daily to Stay Sharp and Live Longer, Research Find - The Beet - August 19th, 2022
- The Next COVID-19 Booster Shots Will Target Omicron: What to Know - Healthline - August 19th, 2022
- What to eat when you have COVID - Medical News Today - August 19th, 2022
- 3 Ways Good Inflammation Helps Your Body - First For Women - August 19th, 2022
- Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs | Scientific Reports -... - August 19th, 2022
- Nasal vaccines could snuff out COVID, but the hurdles are not to be sneezed at - Sydney Morning Herald - August 19th, 2022
- Paxlovid Rebound: RWE Analysis and Alternative Therapies in Development - BioSpace - August 19th, 2022
- Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment - Nature.com - August 19th, 2022
- What Happens When Your Immune System Gets Stressed Out? - Cleveland Clinic - July 8th, 2022
- Alcohol and the Immune System - PMC - PubMed Central (PMC) - July 8th, 2022
- Small NIH study reveals how immune response triggered by COVID-19 may damage the brain - National Institutes of Health (.gov) - July 8th, 2022
- Hyperactivation of the immune system may cause post-COVID syndromes - EurekAlert - July 8th, 2022
- Stress accelerates aging of the immune system - Open Access Government - July 8th, 2022
- Fight off Stress With Immune-Boosting Nutrients the right way - Longevity LIVE - July 8th, 2022
- Toxic chemical that can disrupt reproductive and immune system found in drinking water across country: Report - Times Now - July 8th, 2022
- COVID-19 and Osteoarthritis: Potential Connection and Outlook - Healthline - July 8th, 2022
- What is Your Gut Telling You? - Shepherd Express - July 8th, 2022
- How three kids got kidney transplants without immunosuppressants - Freethink - July 8th, 2022
- Coronavirus explainer: Can drinking green tea help with COVID symptoms? - Times of India - July 8th, 2022
- Immunization reduces the death rate in newborns - Times of India - July 8th, 2022